Please ensure Javascript is enabled for purposes of website accessibility

Verizon and Mobile Health: It's Bigger Than You Think

By Rex Moore and Max Macaluso – Feb 5, 2014 at 2:30PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Verizon’s health care practice develops solutions ranging from remote monitoring to mobile prescriptions. And it's a multibillion-dollar business.

Most of us think of Verizon (VZ 1.67%) in terms of its telecom business, but this global giant also has a large health care branch, including a chief medical officer.

Verizon had a large presence at the recent mHealth Summit near Washington, D.C. -- a large show that sits squarely at the intersection of mobile technology and health care. The Fool's Max Macaluso and Rex Moore attended the fifth-annual summit to learn where mobile health is today and what lies ahead. While there, they chatted with Nancy Green, managing principal of Verizon's health care practice, to learn more about the company's multibillion dollar health segment.

In this video, Nancy talks about some of the products Verizon provides.

A full transcript follows the video.

A stock with tremendous potential for 2014...
There’s a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it’s one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Max Macaluso: Can you run down a few of your top products for us?

Nancy Green: We're at the mHealth show, so let me start there.

At the mHealth show we're highlighting our Converged Health Management product, which is that remote patient monitoring, Class II device -- although it's cloud-based, so it's a little different -- which works with weight scales and blood pressure cuffs and pulse oximeters, that kind of stuff; so that's in mobile health.

We'll be coming out with some other products that add video to it, so we have video products, Universal Identity security work. The Universal Identity is a product that Verizon has. It's a couple years old. We have applied it to health care and fixed a couple problems in health care utilizing the authentication of you and I -- authentication of the consumer, or authenticating a person; a clinician, in this instance.

What we've been able to do, to work with electronic health records in pharmacies, is to do electronic prescriptions in a mobile environment. That's for Schedule II drugs, which are narcotics, which is very difficult to do.

We worked through all that process so that a physician can actually do it, prescribing a Schedule II drug, over his mobile or his device. It's very innovative, because it helps them be able to be on the move -- back to my point of mobile health.

Max Macaluso, Ph.D. has no position in any stocks mentioned. Rex Moore has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Nearly 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Verizonmmunications Stock Quote
Verizonmmunications
VZ
$38.98 (1.67%) $0.64

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
349%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/30/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.